Literature DB >> 16446107

Three kinships with ALAS2 P520L (c. 1559 C --> T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload.

Pauline L Lee1, James C Barton, Sreenivas V Rao, Ronald T Acton, Brian K Adler, Ernest Beutler.   

Abstract

Mutations in aminolevulinate synthase 2 (ALAS2) are usually associated with sideroblastic anemia and iron overload. The objective of this study was to determine if "mild" mutations in ALAS2 might increase the severity of primary iron overload. Direct sequencing of the ALAS2 gene was performed on 24 subjects with primary hemochromatosis and one subject with sideroblastic anemia with severe iron overload. We identified a novel mutation P520L (c. 1559 C --> T) in ALAS2 in three subjects. Two had severe iron overload and no anemia: one also had HFE C282Y homozygosity, and the other was wildtype for HFE and other iron-related genes. The third subject had sideroblastic anemia with iron overload, and was hemizygous for both P520L and R560H (c. 1679 G --> A) mutations in ALAS2. The P520L mutation was found at a frequency of 0.0013 (741 alleles) in white control subjects, but was not found in 158 alleles from black control subjects. The proline in this position is highly conserved across species from humans to zebrafish. However, genotype/phenotype studies of the families demonstrate that the P520L mutation alone has no iron-associated phenotype, but it may act as a modifier of iron overload in the presence of mutations in HFE or other uncharacterized hemochromatosis genes. Thus, ALAS2 mutations might contribute to more severe iron loading in persons with primary hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446107     DOI: 10.1016/j.bcmd.2005.12.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  Postsplenectomy thromboembolic disease in congenital sideroblastic anaemia.

Authors:  Michael T Byrne; Anke K Bergman; Angela I Ruiz; Bernard J Silver; Jaroslaw P Maciejewski; Ramon V Tiu
Journal:  BMJ Case Rep       Date:  2010-09-17

Review 2.  X-linked sideroblastic anaemia in a female fetus: a case report and a literature review.

Authors:  Diane Nzelu; Panicos Shangaris; Lisa Story; Frances Smith; Chinthika Piyasena; Jayanthi Alamelu; Amira Elmakky; Maria Pelidis; Rachel Mayhew; Srividhya Sankaran
Journal:  BMC Med Genomics       Date:  2021-12-20       Impact factor: 3.063

3.  X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).

Authors:  David F Bishop; Vassili Tchaikovskii; A Victor Hoffbrand; Marie E Fraser; Steven Margolis
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

4.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

5.  Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis.

Authors:  Hualin Sun; Ming Li; Yanan Ji; Jianwei Zhu; Zehao Chen; Lilei Zhang; Chunyan Deng; Qiong Cheng; Wei Wang; Yuntian Shen; Dingding Shen
Journal:  Antioxidants (Basel)       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.